C Terry Vance's Insider Trades & SAST Disclosures

C Terry Vance's most recent trade in Enanta Pharmaceuticals Inc was a trade of 15,700 Stock Option (right to buy) done . Disclosure was reported to the exchange on March 13, 2025.

Share

Note

This is a custom search result for pattern C Terry Vance.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Enanta Pharmaceuticals Inc	Terry C. Vance	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Mar 2025	15,700	15,700	-		-	Stock Option (right to buy)
Enanta Pharmaceuticals Inc	Terry C. Vance	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Mar 2024	15,700	15,700	-		-	Stock Option (right to buy)
Enanta Pharmaceuticals Inc	C Terry Vance	Director	Sale of securities on an exchange or to another person at price $ 9.12 per share.	13 Dec 2023	15,295	5,800 (0%)	0%	9.1	139,490	Common Stock
Enanta Pharmaceuticals Inc	Terry C Vance	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.00 per share.	16 Mar 2023	5,800	21,095 (0%)	0%	14	81,200	Common Stock
Enanta Pharmaceuticals Inc	Terry C Vance	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2023	5,800	0	-		-	Stock Option (right to buy)
Enanta Pharmaceuticals Inc	Terry C Vance	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Mar 2023	10,800	10,800	-		-	Stock Option (right to buy)
Enanta Pharmaceuticals Inc	Terry C Vance	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Mar 2022	7,500	7,500	-		-	Stock Option (right to buy)
Enanta Pharmaceuticals Inc	Terry C Vance	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Mar 2021	7,500	7,500	-		-	Stock Option (right to buy)

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades